BORG PHARMACEUTICAL INDUSTRIES

is an Egyptian Share Holding Company

Established according to the investment law for the purpose of manufacture, packaging and distribution of pharmaceuticals, cosmetics and dietary food products to be marketed locally and exported to other countries.

The Company was founded in November 2001 by a group of Egyptian Pharmacists,
Health Professionals & Businessmen. Dr. Hisham Hussein Sarwat Hagar is the Initial Founder & Representative of the Founders.

The feasibility studies and factory design were completed in November 2002.

The construction of the company started in January 2003 and was completed within 16 months including machinery installation.

The Factory was licensed for pharmaceutical production by the Ministry of  Health in June 2004.

Production started in July 2004.

The company capital increased from 7 Millions L.E. in 2001 to 42 Millions L.E.  in 2004 and reached 45 Millions L.E. in 2005  rising to  50 Millions  L.E.  in 2008 .

In December 2009 , Borg Integrated Management System has been certified by TÜV –
SÜD to be fulfilling the requirements of ISO 9001:2008, ISO 14001:2004 and ISO
18001:2007

about-comp

Authorized Manufacturing Activities


BORG PHARMACEUTICAL INDUSTRIES has a valid manufacturing license No. 3/2004 issued by the Egyptian Ministry of Health for the manufacture of following types of human non-sterile dosage forms:
Solid dosage forms ( Tablets -Hard Gelatin Capsules- powder filled in sachets )
Liquid dosage forms ( Syrup – Suspension –Solutions for external use )
Semi-solid dosage forms ( Ointment – Cream – Gel )

Company’s Range of Products

BORG PHARMACEUTICAL INDUSTRIES Products cover the following
pharmacological groups:
  • Anti-infective /Anti-diarrheal
  • Antacid
  • Antiallergic-topical
  • Anti-anemic-oral
  • anti-anemic-parentral
  • Antibiotic- ophthalmic
  • Antibiotic-oral
  • Anti-depressant agent
  • Antiepileptic-diabetic neuropathy
  • Antihyperlipidemia
  • Anti- platlet aggregation
  • Anti diabetic
  • Anti-psoriatic agent
  • Anti hypertensive
  • Artificial sweetener
  • Anti viral
  • Cough suppressant
  • Cognitive enhancer
  • Cosmetic preparations
  • Gastro- prokinetic agent
  •  Multi-vitamin
  • Mucolytics
  • NSAID oral
  • NSAID and decongestant oral
  • Oral anti-histamines
  • Oral Bronchodilator
  • Oral corticosteroid
  • Productive cough preparations
  • Proton pump inhibitor
  • Topical Corticosteroid and anti-fungal
  • Treatment and prevention of  osteoporosis
  • Topical Anti-acne p reparations
  • Topical antibiotic and local anesthetic
  • Topical anti-rheumatic
  • Topical Corticosteroid
  • Urinary incontinence Treatment
  • Vitamin B12 supplement
photo-sec-3

BORG PHARMACEUTICAL INDUSTRIES established, documented, implemented and maintains an Integrated Total Quality Management System and continually improves its effectiveness in accordance with the requirements of the International Standards ISO 9001:2008 / ISO 14001:2004 / OHSAS 18001:2007. Refer to Integrated Total Quality Management System Manual

about-lab-photo

THE CORE ELEMENTS OF THE POLICY OF BORG PHARMACEUTICAL INDUSTRIES ARE:

  • Establishing, implementing, maintaining and continually improving a strong integrated management system that meets the international standards; ISO 9001: 2008 for quality management systems, ISO 14001: 2004 for environment and OHSAS 18001:2007 for occupational health & safety and supports cGMP requirements.
  • Ensuring the sustainability of distinct quality, efficiency and continual improvement, through commitment to the following principles:
    • Enhancing quality culture for employees and customers.
    • Effective implementation of rules and guidelines of cGMP.
    • Continual enhancement of performance, competence and awareness of employees concerning safety measures and environmental protection.
    • Waste minimization and optimum use of materials and energy.
    • Controlling occupational health and safety risks associated with operations.
    • Compliance to the applicable environmental and occupational health and safety, legal and other requirements.
    • Effective customer communication.
    • Setting and continually reviewing the company objectives.
    • Improving and continuously upgrading performance of the integrated management system through ongoing evaluation by developing methods for processes’ measurement and by conducting objective internal audits and management review.
IMG_0936-1024x682
IMG_1010-1024x682

THE STRATEGIC GOALS OF BORG PHARMACEUTICAL INDUSTRIES INCLUDE:

  • Design, development and production of safe, effective and stable pharmaceuticals, cosmetics and dietary supplement with superior quality, complying with cGMP requirements and fulfilling customers’ needs.
  • Effective contribution in supporting and developing the health and economic systems.
  • Contribution in activating the Pharmacovigilance procedures and activities in order to ensure marketing of safe and effective medicines which is considered the main objective of the Egyptian Pharmacovigilance Center.
  • Satisfying local market requirements of products that can replace the imported ones.
  • Promoting the company’s reputation and competitive edge.
  •  Enhancing exportation opportunities.
  • Achieving business success and improving profitability taking into consideration assigning competitive prices.
  • Attaining customer loyalty through transparency in communication.
  • Providing a safe and healthy work environment for employees, neighboring facilities and community.

periodically reviews this policy; and makes it available to all employees, to interested parties and to the public.

IMG_0876
IMG_1020-1024x682

Quality Assurance Responsibilities

It is the responsibility of Quality Assurance to ensure the following:
  • All products are designed and developed in a way which takes in account GMP
    requirements.
  • Production and control operations are clearly specified and GMP adopted
  • Follow up of implementation of validation protocols.
  • All necessary control on starting materials and bulk products are carried out. In addition all performed in-process controls are recorded.
  • Control of any actual or potential non conformance.
  • The Finished product is correctly checked against approved specifications.
  • Release of finished products for sale is only issued after accurate review of batch records.
  • Follow up of batches’ productiveness and losses.
  • Change control arrangements are carried out according to approved procedure.
  • There is a procedure for self – inspection which regularly appraises the effectiveness and applicability of the QA system.
  • Contribution in suppliers’ audits.
  • Follow up of external audits results that are carried out by health authorities, certification bodies, or by export committees.
  • Effective documents control system to ensure that relevant versions of applicable documents are available at points of use.
  • Follow up of customer complaints to ensure effective elimination of causes.
  • Maintaining a documented procedure for products recall.
  • Conducting regular reviews on product quality according to annual product review procedure.
  • Preparation of reports for management review meetings.
  • Maintaining an effective quality system complying with the requirements of
    international standards of Quality, Environment, Occupational health and safety to achieve total quality management.
IMG_0986
IMG_0985
IMG_0982

our gallery